Compare DXR & SDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXR | SDEV |
|---|---|---|
| Founded | 1970 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 65.3M |
| IPO Year | 1995 | 2007 |
| Metric | DXR | SDEV |
|---|---|---|
| Price | $10.98 | $3.66 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 40.7K | ★ 5.9M |
| Earning Date | 11-13-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 2.77 |
| Revenue | ★ $1,446,345.00 | $370,000.00 |
| Revenue This Year | $44,489.33 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ $0.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.56 | $0.78 |
| 52 Week High | $14.76 | $3.40 |
| Indicator | DXR | SDEV |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 82.32 |
| Support Level | N/A | $0.93 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.30 |
| MACD | 0.00 | 0.27 |
| Stochastic Oscillator | 0.00 | 95.70 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.